290 related articles for article (PubMed ID: 10729359)
1. Cytochrome P450-dependent N-dealkylation of L-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, beta-naphthoflavone and L-deprenyl.
Valoti M; Fusi F; Frosini M; Pessina F; Tipton KF; Sgaragli GP
Eur J Pharmacol; 2000 Mar; 391(3):199-206. PubMed ID: 10729359
[TBL] [Abstract][Full Text] [Related]
2. l-Deprenyl metabolism by the cytochrome P450 system in monkey (Cercopithecus aethiops) liver microsomes.
Dragoni S; Bellik L; Frosini M; Sgaragli G; Marini S; Gervasi PG; Valoti M
Xenobiotica; 2003 Feb; 33(2):181-95. PubMed ID: 12623760
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450-dependent metabolism of l-deprenyl in monkey (Cercopithecus aethiops) and C57BL/6 mouse brain microsomal preparations.
Dragoni S; Bellik L; Frosini M; Matteucci G; Sgaragli G; Valoti M
J Neurochem; 2003 Sep; 86(5):1174-80. PubMed ID: 12911625
[TBL] [Abstract][Full Text] [Related]
4. N-Dealkylation of chlorimipramine and chlorpromazine by rat liver microsomal cytochrome P450 isoenzymes.
Valoti M; Frosini M; Palmi M; De Matteis F; Sgaragli G
J Pharm Pharmacol; 1998 Sep; 50(9):1005-11. PubMed ID: 9811161
[TBL] [Abstract][Full Text] [Related]
5. CYP-dependent metabolism of PF9601N, a new monoamine oxidase-B inhibitor, by C57BL/6 mouse and human liver microsomes.
Dragoni S; Materozzi G; Pessina F; Frosini M; Marco JL; Unzeta M; Sgaragli G; Valoti M
J Pharm Pharm Sci; 2007; 10(4):473-85. PubMed ID: 18261369
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency.
Yoshida T; Yamada Y; Yamamoto T; Kuroiwa Y
Xenobiotica; 1986 Feb; 16(2):129-36. PubMed ID: 3083608
[TBL] [Abstract][Full Text] [Related]
7. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
[TBL] [Abstract][Full Text] [Related]
8. Activation of alkylhydrazines to free radical intermediates by ethanol-inducible cytochrome P-4502E1 (CYP2E1).
Albano E; Comoglio A; Clot P; Iannone A; Tomasi A; Ingelman-Sundberg M
Biochim Biophys Acta; 1995 Apr; 1243(3):414-20. PubMed ID: 7727516
[TBL] [Abstract][Full Text] [Related]
9. The role of different cytochrome P450 isoforms in in vitro chloroform metabolism.
Testai E; De Curtis V; Gemma S; Fabrizi L; Gervasi P; Vittozzi L
J Biochem Toxicol; 1996; 11(6):305-12. PubMed ID: 9176742
[TBL] [Abstract][Full Text] [Related]
10. Atypical metabolism of deprenyl and its enantiomer, (S)-(+)-N,alpha-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6.
Grace JM; Kinter MT; Macdonald TL
Chem Res Toxicol; 1994; 7(3):286-90. PubMed ID: 8075358
[TBL] [Abstract][Full Text] [Related]
11. Selegiline metabolism and cytochrome P450 enzymes: in vitro study in human liver microsomes.
Taavitsainen P; Anttila M; Nyman L; Karnani H; Salonen JS; Pelkonen O
Pharmacol Toxicol; 2000 May; 86(5):215-21. PubMed ID: 10862503
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M
FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468
[TBL] [Abstract][Full Text] [Related]
13. Distinct effects of form selective cytochrome P450 inhibitors on cytochrome P450-mediated monooxygenase and hydrogen peroxide generating NADPH oxidase.
Mishin V; Heck DE; Jan YH; Richardson JR; Laskin JD
Toxicol Appl Pharmacol; 2022 Nov; 455():116258. PubMed ID: 36174671
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochrome P-450 inducers.
Crosbie SJ; Blain PG; Williams FM
Hum Exp Toxicol; 1997 Mar; 16(3):131-7. PubMed ID: 9088965
[TBL] [Abstract][Full Text] [Related]
15. Ethanol-inducible microsomal aniline hydroxylase activity and cytochrome P-450 isozymes in adult hen liver.
Gupta RP; Abou-Donia MB
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Apr; 101(3):505-12. PubMed ID: 1354126
[TBL] [Abstract][Full Text] [Related]
16. Evidence supporting the interaction of CYP2B4 and CYP1A2 in microsomal preparations.
Cawley GF; Zhang S; Kelley RW; Backes WL
Drug Metab Dispos; 2001 Dec; 29(12):1529-34. PubMed ID: 11717170
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
Shaik AN; LeDuc BW; Khan AA
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):827-834. PubMed ID: 28185143
[TBL] [Abstract][Full Text] [Related]
18. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes.
Menicagli S; Lippi A; Criscuoli M; Gervasi PG
Biochem Pharmacol; 1993 Mar; 45(5):1097-105. PubMed ID: 8461039
[TBL] [Abstract][Full Text] [Related]
19. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J
Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706
[TBL] [Abstract][Full Text] [Related]
20. Induction of multiple forms of mouse liver cytochrome P-450. Evidence for genetically controlled de novo protein synthesis in response to treatment with beta-naphthoflavone or phenobarbital.
Haugen DA; Coon MJ
J Biol Chem; 1976 Mar; 251(6):1817-27. PubMed ID: 1254598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
